Prevention of venous thromboembolism in patients with stroke--enoxaparin vs unfractionated heparin

Affiliations

Comment

Richard A Bernstein. Nat Clin Pract Neurol. 2007 Oct.

. 2007 Oct;3(10):542-3.

doi: 10.1038/ncpneuro0613. Epub 2007 Sep 11.

¹ Department of Neurology at the Feinberg School of Medicine of Northwestern University, Chicago, IL 60026, USA. r-bernstein@northwestern.edu

No abstract available

Comment on

The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison.
Sherman DG, Albers GW, Bladin C, Fieschi C, Gabbai AA, Kase CS, O'Riordan W, Pineo GF; PREVAIL Investigators. Sherman DG, et al. Lancet. 2007 Apr 21;369(9570):1347-1355. doi: 10.1016/S0140-6736(07)60633-3. Lancet. 2007. PMID: 17448820 Clinical Trial.